CXCL10 and glioblastoma: In the present study, we used a new cascade targeting strategy with angiopep-2 and IP10-EGFRvIIIscFv fusion proteins, and assessed the efficacy of the strategy for targeting of brain glioblastoma cells and recruitment of activated CD8+ T lymphocytes to the location of glioblastoma cells.